-
1
المؤلفون: Johanna Lilja, Ella-Maria Vesilahti, Johanna M. Anttila, Hussein Al-Akhrass, Johanna Ivaska, Emilia Peuhu, Pauliina Munne, Mika Pietilä, Juha Klefström, Heidi M. Haikala
المساهمون: HUS Comprehensive Cancer Center, Faculty of Medicine, CAN-PRO - Translational Cancer Medicine Program, University Management
المصدر: Molecular Oncology
Molecular Oncology, Vol 16, Iss 1, Pp 116-129 (2022)مصطلحات موضوعية: Cancer Research, Receptor, ErbB-3, Receptor, ErbB-2, Druggability, Mice, 0302 clinical medicine, DOMAIN, Trastuzumab, PHOSPHORYLATION, ERBB2, Receptor, skin and connective tissue diseases, RC254-282, Research Articles, 0303 health sciences, biology, Kinase, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antibodies, Monoclonal, General Medicine, receptor trafficking, 3. Good health, AMYLOID PRECURSOR PROTEIN, SorLA, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Antibody, medicine.drug, Research Article, Combination therapy, medicine.drug_class, 3122 Cancers, Antineoplastic Agents, Breast Neoplasms, Monoclonal antibody, 03 medical and health sciences, Breast cancer, breast cancer, LAPATINIB, HER3, HER2, Cell Line, Tumor, Genetics, medicine, Animals, Humans, neoplasms, 030304 developmental biology, business.industry, medicine.disease, Adaptor Proteins, Vesicular Transport, ANTIBODY, Drug Resistance, Neoplasm, CELLS, biology.protein, Cancer research, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5e1dde49b49e80f1d369ac8daa1309Test
http://europepmc.org/articles/PMC8732349Test -
2
المؤلفون: Johanna M. Anttila, Emilia Peuhu, Johanna Ivaska, Ella-Maria Vesilahti, Juha Klefström, Mika Pietilä, Pauliina Munne, Heidi M. Haikala, Johanna Lilja, Hussein Al-Akhrass
مصطلحات موضوعية: Breast cancer, business.industry, medicine, Cancer research, Druggability, Receptor, medicine.disease, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9576be0c477eec6ed465d28ee922ac3aTest
https://doi.org/10.1002/1878-0261.13106/v2/response1Test